The nomination period is now open for the 2013 M. Jeang Retrovirology Prize. Nominations will be accepted from December 1st, 2012 to January 15th, 2013. The winner of the 2013 Retrovirology Prize will be announced and presented at the 2013 Frontiers in Retrovirology conference to be held September 16-18th at Cambridge University in the UK http://www.frontiers-of-retrovirology.com/ . Please see the following articles for rules in nominating a candidate for the Retrovirology Prize http://www.retrovirology.com/content/pdf/1742-4690-9-96.pdf ; http://www.retrovirology.com/content/pdf/1742-4690-5-80.pdf . We encourage your nomination of a deserving colleague. If you have any questions about the Retrovirology Prize, please feel free to contact the editors at firstname.lastname@example.org .
Posts by Kuan-Teh Jeang
The Department of Molecular Virology and Microbiology at Baylor College of Medicine invites applications for a tenured or tenure-track faculty position focused on any area of HIV/AIDS research. Preference will be given to applicants with an established research program. The successful candidate is expected to maintain an innovative funded research program and to participate in graduate training. Generous start-up funds are available.
Baylor College of Medicine is located in the rich scientific setting of the renowned Texas Medical Center, the largest incorporated medical center in the world, in Houston, a dynamic and ethnically diverse city with many cultural amenities. State-of-the-art core facilities are available. Multidisciplinary research centers, including the Center for AIDS Research, the Dan L. Duncan Cancer Center, the Alkek …
Postdoctoral Fellow Position Available
Laboratory of Molecular Virology
A Postdoctoral Fellow position is available in a research program supported by
the European Research Council (ERC Advanced Grant) focused on
understanding the molecular basis for HIV-1 transcriptional silencing.
Applicants are invited for a 2 to 3 years Post-doctoral Research Position. The
research program will require expertise in the field of transcription, chromatin
(genome wide analyses) and biochemistry.
The Institute of Human Genetics (http://www.igh.cnrs.fr/) is a major CNRS unit
dedicated to excellence in fundamental research and pathology. The principal
research interests of the IGH are genome dynamics, developmental genetics,
epigenetics, and molecular and cellular pathology. The institute is located in
Montpellier, one of the most lively and concentrated areas for research
scientists in France. Please …
Li Wu wrote the following for me to post on the Retrovirology Blog:
Because of rapid research progress and advances in the techniques in studying HIV interactions with host cells and factors, there is a critical need for a book on HIV interactions with dendritic cells. Two editorial broad members of Retrovirology, Dr. Li Wu (The Ohio State University, USA) and Dr. Olivier Schwartz (Institut Pasteur, France), have edited a new book entitled HIV Interactions with Dendritic Cells Infection and Immunity.
The book has been published by Springer (New York) in September 2012, which Systematically addresses HIV interactions with dendritic cells with emphasis on HIV infection and immunity; Features state-of-the-art research on HIV interactions with dendritic cells using virological and immunological approaches; Provides …
New young group leader opportunities in microbiology and virology available at Pasteur Institute, Paris. Please see the following link for more information. IBEID call Pasteur
Pat Green and Li Wu have asked me to post the following job announcement of an opening available at Ohio State University. Please visit the web link if you are interested:
If you have job announcement that you would like to post at Retrovirology, please feel free to contact me.
Below is a tabulation of 2011 Impact Factors for several retrovirus-relevant journals. The Immediacy Index is a reflection of how rapidly a paper published in a journal is cited immediately after its publication. The higher the Immediacy Index means that the paper is cited more quickly.
The 2011 Impact Factor for journals tracked by ISI Reuters Thomson has been released. Retrovirology’s new Impact Factor places it at the forefront of virology journals that publish orginal basic research. A listing of Retrovirology and competitor journals is enumerated as follows:
Retrovirology (6.470), AIDS (6.245), Journal of Virology (5.402), J. General Virology (3.363 ), Virology (3.351), AIDS Res. and Human Retroviruses (2.246) and Viruses (1.500).
I recently attended the ESF Research Conference "Antiviral RNAi" June 11-15th in Pultusk, Poland. Ben Berkhout, one of Retrovirology’s Associate editors, was a co-organizer of the meeting. Below is a group picture taken at the Polonia Castle in Pultusk. Several very interesting talks were presented at this conference, and a meeting report is slated to be published in EMBO Reports soon; so keep your eyes out for that writeup. Coincidentally, a few days ago, I wrote a short Opinion piece for BMC Biology on RNAi and mammalian viruses. http://www.biomedcentral.com/1741-7007/10/58 It makes for brief reading; so take a look if you are interested in this topic.
Retrovirology publishes meeting Abstracts as supplements to the journal. This is a service that we provide to the retrovirus research community. On our supplements page http://www.retrovirology.com/supplements, you can view Abstracts from 10 meetings that have been published in Retrovirology, including the recent
Abstracts from the 17th International Symposium on HIV and Emerging Infectious Diseases (ISHEID) http://www.retrovirology.com/supplements/9/S1. Occasionally, colleagues would ask me "What are the advantages of publishing meeting Abstracts in a journal like Retrovirology compared to simply publishing the Abstracts in a meeting book?" There are several benefits. First, a meeting book is accessible only to meeting participants; publishing your Abstract in Retrovirology provides immediate Open Access visibility and accessibility to your work by all interested colleagues who are unable …